- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Smokers more likely to develop Schizophrenia: Study
Active smoking affects the chemical composition in the brain, and can instigate direct role in the development of schizophrenia. The study also reports that 57 percent of people with psychosis were already smokers when they had their first psychotic episode
Well, there is another set of bad news for the smokers. The latest findings in the research at King’s College London, now directly blames the nicotine of altering levels of brain chemical dopamine. Thus acts as a strong catalyst for development of schizophrenia as a serious mental disorder at a young age.
It has been further investigated in the study that smokers develop schizophrenia a year earlier on average. On the matter of debate if there's a higher rate of smoking before schizophrenia is diagnosed, then smoking is not simply a case of self-medication. However, more research is still required on the subject.
The data, published in the Lancet Psychiatry indicated that 57 percent of people with psychosis were already smokers when they had their first psychotic episode, and daily smokers were twice as likely to develop schizophrenia as non-smokers.
As reported by ANI,
Dr James MacCabe said that it was hard to establish causation with this style of study, and they hoped that it would lead to other researches and clinical trials that would help to provide firmer evidence.
While most smokers do not develop schizophrenia, the researchers believe it add to the risk as nicotine altered levels of the brain chemical dopamine, which has already been implicated in the psychosis.
Well, there is another set of bad news for the smokers. The latest findings in the research at King’s College London, now directly blames the nicotine of altering levels of brain chemical dopamine. Thus acts as a strong catalyst for development of schizophrenia as a serious mental disorder at a young age.
It has been further investigated in the study that smokers develop schizophrenia a year earlier on average. On the matter of debate if there's a higher rate of smoking before schizophrenia is diagnosed, then smoking is not simply a case of self-medication. However, more research is still required on the subject.
The data, published in the Lancet Psychiatry indicated that 57 percent of people with psychosis were already smokers when they had their first psychotic episode, and daily smokers were twice as likely to develop schizophrenia as non-smokers.
As reported by ANI,
Dr James MacCabe said that it was hard to establish causation with this style of study, and they hoped that it would lead to other researches and clinical trials that would help to provide firmer evidence.
While most smokers do not develop schizophrenia, the researchers believe it add to the risk as nicotine altered levels of the brain chemical dopamine, which has already been implicated in the psychosis.
Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751
Next Story